PHASE Scientific Americas a high-growth biotech company founded by bioengineers from UCLA, announces that its EUA approved INDICAID COVID-19 Rapid Antigen At-Home Test (INDICAID OTC) is now available for non-prescription home use in the United States through its new Shop INDICAID
online store,
shop.indicaidusa.com.
The INDICAID COVID-19 Rapid Antigen At-Home Test is authorized for nonprescription home use with self-collected shallow nasal samples for individuals aged 14 years or older, or adult-collected nasal samples from individuals aged 2 years or older, with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests.
The performance of INDICAID for professional use was published in a peer-reviewed article in the American Society for Microbiology’s journal,
Microbiology Spectrum. The piece shares data from a prospective multi-site U.S. clinical study, in which INDICAID demonstrated strong performance, accurately identifying 85% of those who were positive (PPA) and 97% of those who were negative (NPA) for SARS-CoV-2 with self-collected specimens. INDICAID
® has also been
confirmed to detect COVID-19 Omicron variants based on an independent evaluation by the National Institutes of Health (NIH) RADx Variant Task Force.